|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/04 | |
| C07D 403/04 | |||
| C07D 417/04 | |||
| C07D 471/04 | |||
| C07D 487/04 | |||
| A61K 31/4164 | |||
| A61K 31/426 | |||
| A61P 35/00 |
| (11) | Number of the document | 3265454 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16710547.7 |
| Date of filing the European patent application | 2016-02-26 | |
| (97) | Date of publication of the European application | 2018-01-10 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/019830 |
| Date | 2016-02-26 |
| (87) | Number | WO 2016/140884 |
| Date | 2016-09-09 |
| (30) | Number | Date | Country code |
| 201562127109 P | 2015-03-02 | US |
| (72) |
KINSELLA, Todd, US
GELMAN, Marina, US
HONG, Hui, US
DARWISH, Ihab, S., US
SINGH, Rajinder, US
YU, Jiaxin, US
BORZILLERI, Robert, M., US
VELAPARTHI, Upender, US
LIU, Peiying, US
DARNE, Chetan, US
RAHAMAN, Hasibur, IN
WARRIER, Jayakumar, Sankara, IN
|
| (73) |
Rigel Pharmaceuticals, Inc.,
1180 Veterans Boulevard, South San Francisco, CA 94080,
US
Bristol-Myers Squibb Company, Route 206 and Province Line Road, Princeton, NJ 08543, US |
| (54) | TGF-BETA INHIBITORS |
| TGF-BETA INHIBITORS |